Clinical Trial Update: Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the dose-response of droxidopa for orthostatic hypotension in individuals with spinal cord injury; results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Orthostatic Hypotension
• Spinal Cord Injury

Drugs mentioned

• Northera (droxidopa)

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Hypotension, Orthostatic, Hypotension | Phase 4 | Status: COMPLETED | Results posted: 2025-03-07